25-02
Morel Mushrooms Due to Adulteration
1 firm from 1 country is named on this alert. Their shipments may be detained at the port without physical examination. The oldest listing here dates to 16 September 2009.
- 1firm listed
- 1country
- 31 July 2026alert last published
- Source on FDA →accessdata.fda.gov
Why FDA issued it
NOTE: The revision to this import alert dated 05/23/2022 updates the title of the alert, guidance section, charge section, and PAF/PAC sections. Changes are bracketed by asterisks (***). In the past, shipments of canned and dried morel mushrooms have been detained due to the presence of Gyromitra esculenta. This mushroom species is known to produce monomethylhydrazine (MMH), a substance which causes severe gastrointestinal disturbance and, in some cases, death. In addition to Gyromitra esculenta, CFSAN has identified another species, Verpa bohemica, which can also cause toxic effects in some individuals.
Quoted from the “Reason for Alert” section of the FDA page for 25-02, mirrored 30 August 2026. The quotation is truncated at the length this copy carries.
Firms named on 25-02
| Firm | Country | Listed since | |
|---|---|---|---|
| Plantin SASRoute De Nyons , Puymeras, Vaucluse FRANCE | France | 16 Sep 200916 yr |